Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Gedeon PC"'
Autor:
Ramapriyan R; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA., Sun J; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA., Curry A; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA., Richardson LG; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA., Ramesh T; Harvard Medical School, Boston, MA 02115, USA., Gaffey MA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA., Gedeon PC; Harvard Medical School, Boston, MA 02115, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA., Gerstner ER; Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA., Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2023 Nov 13; Vol. 12 (4). Date of Electronic Publication: 2023 Nov 13.
Autor:
Nakazawa S; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nagashima T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan., Kawatani N; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan., Gedeon PC; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., DeSimone AK; Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Igai H; Department of General Thoracic Surgery, Japanese Red Cross Maebashi Hospital, Maebashi, Japan., Kosaka T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.; Department of Thoracic Surgery, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan., Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Publikováno v:
Video-assisted thoracic surgery [Video Assist Thorac Surg] 2023 Jun 30; Vol. 8. Date of Electronic Publication: 2023 May 24.
Autor:
Nobili A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Current Address: Dynamic Cell Therapies, Inc., 127 Western Ave., Allston, MA 02134, USA., Kobayashi A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Gedeon PC; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Surgery, Harvard Medical School, Boston, MA 02115, USA., Novina CD; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Publikováno v:
Journal of cancer immunology [J Cancer Immunol (Wilmington)] 2022; Vol. 4 (2), pp. 52-59.
Autor:
Gedeon PC; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School , Boston, MA, USA., Champion CD; Department of Neurosurgery, Duke University Medical Center , Durham, NC, USA., Rhodin KE; Department of Surgery, Duke University Medical Center , Durham, NC, USA., Woroniecka K; Department of Neurosurgery, Duke University Medical Center , Durham, NC, USA.; Department of Pathology, Duke University Medical Center , Durham, NC, USA., Kemeny HR; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine , Chicago, IL, USA., Bramall AN; Department of Neurosurgery, Duke University Medical Center , Durham, NC, USA., Bernstock JD; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School , Boston, MA, USA., Choi BD; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA., Sampson JH; Department of Neurosurgery, Duke University Medical Center , Durham, NC, USA.; Department of Pathology, Duke University Medical Center , Durham, NC, USA.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2020 Oct; Vol. 13 (10), pp. 1147-1158. Date of Electronic Publication: 2020 Sep 11.
Autor:
Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; Department of Biomedical Engineering, Duke University, Durham, NC, United States of America.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America., Streicker MA; Integrated Laboratory Systems, Inc., Research Triangle Park, NC, United States of America., Schaller TH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; Department of Pathology, Duke University Medical Center, Durham, NC, United States of America., Archer GE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America., Jokinen MP; Integrated Laboratory Systems, Inc., Research Triangle Park, NC, United States of America., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; Department of Biomedical Engineering, Duke University, Durham, NC, United States of America.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.; Department of Pathology, Duke University Medical Center, Durham, NC, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Jul 31; Vol. 15 (7), pp. e0236374. Date of Electronic Publication: 2020 Jul 31 (Print Publication: 2020).
Autor:
Schaller TH; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States., Snyder DJ; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States., Spasojevic I; PK/PD Core Laboratory, Duke Cancer Institute, Durham, North Carolina, United States.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States., Gedeon PC; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States., Sanchez-Perez L; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States., Sampson JH; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States john.sampson@duke.edu.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Apr; Vol. 8 (1).
Autor:
Suryadevara CM; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Desai R; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Farber SH; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Choi BD; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Swartz AM; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Shen SH; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Gedeon PC; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Snyder DJ; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Healy P; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Reap EA; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Archer GE; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Fecci PE; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sampson JH; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu luis.sanchez-perez@duke.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sanchez-Perez L; Department of Neurosurgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu luis.sanchez-perez@duke.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jan 01; Vol. 25 (1), pp. 358-368. Date of Electronic Publication: 2018 Nov 13.
Autor:
Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Biomedical Engineering, Duke University, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Schaller TH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Chitneni SK; Department of Radiology, Duke University Medical Center, Durham, North Carolina., Choi BD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Kuan CT; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Suryadevara CM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Snyder DJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Schmittling RJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Szafranski SE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Cui X; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Healy PN; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., McLendon RE; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Keir ST; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Archer GE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Reap EA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Bigner DD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu.; Department of Biomedical Engineering, Duke University, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Aug 01; Vol. 24 (15), pp. 3611-3631. Date of Electronic Publication: 2018 Apr 27.
Autor:
Suryadevara CM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Desai R; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC., Abel ML; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC., Riccione KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Biomedical Engineering, Duke University, Durham, NC., Batich KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Shen SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Chongsathidkiet P; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Elsamadicy AA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC., Snyder DJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC.; Duke Cancer Institute Biostatistics, Duke University Medical Center, Durham, NC., Healy P; Duke Cancer Institute Biostatistics, Duke University Medical Center, Durham, NC., Archer GE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Choi BD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; Department of Pathology, Duke University Medical Center, Durham, NC.; Department of Biomedical Engineering, Duke University, Durham, NC., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Feb 21; Vol. 7 (6), pp. e1434464. Date of Electronic Publication: 2018 Feb 21 (Print Publication: 2018).
Autor:
Reap EA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Suryadevara CM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Batich KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Archer GE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Schmittling RJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Norberg PK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Healy P; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Congdon KL; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Campbell OC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Swartz AM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Riccione KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Yi JS; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Hossain-Ibrahim MK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Saraswathula A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Nair SK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Dunn-Pirio AM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Broome TM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Weinhold KJ; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Desjardins A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurology, Duke University Medical Center, Durham, North Carolina., Vlahovic G; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., McLendon RE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Friedman AH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Friedman HS; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Bigner DD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Mitchell DA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu duane.mitchell@neurosurgery.ufl.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu duane.mitchell@neurosurgery.ufl.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Cancer research [Cancer Res] 2018 Jan 01; Vol. 78 (1), pp. 256-264. Date of Electronic Publication: 2017 Nov 01.